Skip to main content

Mirae Asset — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

196
Companies
$3.7B
Total invested
$94.2M
Avg. check
52
Industries
Artificial Intelligence (AI) 11Software 10Biotechnology 6Health Care 6Therapeutics 5SaaS 3+46 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 196
AmazeVR
September 2022

AmazeVR is a virtual concert platform for VR content creation and mass distribution using proprietary technologies.

Gaming · Los Angeles$20.0M Series B
Nextbillion.ai
September 2022

Nextbillion.ai provides advanced Route Planning & Optimization APIs & SDKs for businesses.

Artificial Intelligence (AI) · Singapore$3.0M Series B
Immunitas Therapeutics
August 2021

Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.

Biotechnology · Cambridge$58.0M Series B
Motion2AI
August 2021

AI-powered Forklift Telematics and Forklift Tracking to prevent accidents and improve utilization.

Artificial Intelligence (AI) · Dallas$12.6M Series A
Felo
July 2025

Felo develops and provides the next-generation AI search and agent platform.

Artificial Intelligence (AI) · Tokyo$10.3M Series A
Navigantis
July 2024

Navigantis empowers physicians to deliver uncompromised neurovascular care by creating a new frontier in surgical robotics.

Health Care · Miami$12.0M Series A
FamePick
July 2021

FamePick offers a platform to connect celebrities with brands for digital endorsements.

Advertising · Redwood City$2.0M Venture - Series Unknown
4D Molecular Therapeutics
June 2026

4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

Biotechnology · Emeryville$200.0M Post-IPO Debt
āshibio
June 2024

āshibio is a privately held biotechnology business exploring innovative therapies to treat bone and connective tissue ailments.

Biotechnology · Brisbane$40.0M Series A
Solana Company
April 2026

Solana Company is a traded enterprise for digital asset management and neurotechnology innovation.

Biotechnology · Newtown$7.9M Post-IPO Equity
XBoost
April 2024

XBoost develops AI agents for online marketplace sellers and brands to automate their growth and operations with breakthrough innovation.

Artificial Intelligence (AI) · Los Angeles$8.6M Series A
AvoMD
March 2026

AvoMD is reimagining decision support with no code software and point-of-care innovation.

Health Care · New York$10.0M Series A
Acticor Biotech
March 2024

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.

Biopharma · Paris$8.7M Post-IPO Equity
Casma Therapeutics
March 2026

Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.

Biotechnology · Cambridge$7.6M Grant
iiRcade
February 2023

Bringing Arcade Gaming to the 21st Century

Console Games · Skokie$2.0M Venture - Series Unknown
ThorDrive
February 2022

ThorDrive is a company that developes software solutions related to automated and unmanned technology.

Artificial Intelligence (AI) · Cincinnati$16.7M Series A
ACT-ion Battery Technologies
September 2025

ACT-ion Battery Technologies is a manufacturing company that offers cathode active materials for lithium batteries.

Dallas$4.0M Seed
Asteromorph
April 2025

Asteromorph is an artificial intelligence (AI) research startup for the development of scientific superintelligence

Artificial Intelligence (AI) · Seoul$3.5M Seed
Vroong
March 2025

Vroong is a highly IT-oriented online logistics company that mainly focuses on developing online real-time same-day delivery platforms.

Delivery Service · Seoul$20.7M Venture - Series Unknown
Nota AI
February 2025

Nota AI is a tech startup with a focus on optimizing AI models with NetsPresso, our proprietary hardware-aware AI optimization platform.

Artificial Intelligence (AI) · SeoulPre-Seed
Mediwhale
September 2024

Medi Whale offers medical AI software for disease detection.

Artificial Intelligence (AI) · Seoul$12.0M Series A
RLWRLD
February 2026

RLWRLD is a software company that develops foundation models through Artificial Intelligence and robotics.

Artificial Intelligence (AI) · Seoul$26.0M Seed
PersonaAI
February 2026

PersonaAI is a conversational AI technology company that provides chatbot, callboat and AI semiconductor Kiosk product and SaaS products.

Artificial Intelligence (AI) · Seoul$7K Grant
Playad.ai
January 2026

Playad.ai develops an AI-native marketing platform for multi-agent ad workflows and interactive ad creatives.

Advertising · South San Francisco$5.4M Pre-Seed

Where Mirae Asset invests

Artificial Intelligence (AI)11
Software10
Biotechnology6
Health Care6
Therapeutics5
SaaS3

About Mirae Asset's portfolio

How many companies has Mirae Asset invested in?

Mirae Asset has invested in 196 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Mirae Asset invest in?

Mirae Asset's top investment sectors include Artificial Intelligence (AI), Software, Biotechnology, Health Care, Therapeutics. The firm invests across 52 different industry categories.

What is Mirae Asset's largest investment?

Among tracked funding rounds, 4D Molecular Therapeutics received $200.0M in a Post-IPO Debt round. Mirae Asset's total known invested capital is $3.7B.

What is the average investment size for Mirae Asset?

Mirae Asset's average investment size is $94.2M across its portfolio of 196 companies.

What are Mirae Asset's most recent investments?

Recent Mirae Asset portfolio additions include AmazeVR, Nextbillion.ai, Immunitas Therapeutics, Motion2AI, Felo. These companies were founded in 2020 or later.

Reach the founders behind these 196 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →